{"product_id":"johns-hopkins-wilmer-eye-institutes-40th-annual-current-concepts-in-ophthalmology-2024","title":"Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch3 class=\"activitysectionbold\"\u003eDate \u0026amp; Location\u003c\/h3\u003e\n\u003cbr\u003eMonday, March 18, 2024, 7:00 AM – Friday, March 22, 2024, 7:00 PM, Vail Marriott, Vail, CO\u003cbr\u003e\u003ch4 class=\"activitysectionbold\"\u003eTarget Audience\u003c\/h4\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Ophthalmology\u003c\/div\u003e\n\u003ch4\u003econtent : 10 videos + 31 pdfs, size: 12.2 GB\u003c\/h4\u003e\n\u003ch3 class=\"activitysectionbold\"\u003eOverview\u003c\/h3\u003e\n\u003cbr\u003eJohns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024 This Current Concepts course will highlight the recent developments regarding diagnosis as well as medical and surgical therapy of common eye diseases. The participant should get a comprehensive review of the most current concepts in the management of ophthalmology by experts across the breadth of the field.\u003cbr\u003e\u003cbr\u003eFor example, clinical trials and other evidence in the peer-reviewed literature over the past few years have changed the approach to managing cataract including IOL technology and femtosecond laser cataract surgery, corneal disease including dry eye disease, keratoplasty, and collagen cross linking, glaucoma and minimally invasive glaucoma surgical devices, as well as diabetic retinopathy, macular degeneration, and retinal vein occlusions. Furthermore, the role of optical coherence tomography (OCT) and other imaging advances are expanding the understanding of the anatomy of the anterior and posterior segment of the eye.\u003cbr\u003e\u003cbr\u003eThis course will address the ongoing pattern of registrants with repeat requests for demonstrations of the latest surgical techniques and medical therapies, questions regarding practice management issues and clarification of legislative updates. There is a demand for expert education of new techniques and medical therapies as well as the need for elucidation of associated clinical trials, and this course provides extensive coverage of that.\u003cbr\u003e\u003ch4 class=\"activitysectionbold\"\u003eObjectives\u003c\/h4\u003e\n\u003col\u003e\n\u003cli\u003eIntegrate prescribed medical and surgical treatment options into everyday practice, including uveitis, oculoplastic and ocular oncology.\u003c\/li\u003e\n\u003cli\u003eAssess the perioperative use of antibiotic and anti-inflammatory agents in patients undergoing eye surgery.\u003c\/li\u003e\n\u003cli\u003eFormulate current and advanced medical and surgical treatment strategies as well as imaging with corresponding ocular conditions, including: glaucoma, retina, anterior segment including “dry eye”, uveitis, refractive surgery and laser assisted cataract and corneal transplant surgery.\u003c\/li\u003e\n\u003cli\u003eDiscuss new medical techniques, therapies and relevant clinical trials in dry eye, refractive surgery, cornea, glaucoma, and retina, including diabetic retinopathy, macular degeneration, and retinal vein occlusion.\u003c\/li\u003e\n\u003cli\u003eAssess the latest developments for the management of pediatric ophthalmology and strabismus conditions.\u003c\/li\u003e\n\u003cli\u003eDescribe unique considerations for cataract surgery in patients with comorbid glaucoma.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAnterior Segment (Cornea) -CHAIR.pdf\u003c\/li\u003e\n\u003cli\u003eAnterior Segment Challenges and Academic Ophthalmology – MODERATOR.pdf\u003c\/li\u003e\n\u003cli\u003eAntibody Drug Conjugate- What are They and What Does An Ophthalmologist Need to Know About Them.pdf\u003c\/li\u003e\n\u003cli\u003eArtificial Intelligence and Retinal Imaging.pdf\u003c\/li\u003e\n\u003cli\u003eBlepharoplasty Basics.pdf\u003c\/li\u003e\n\u003cli\u003eCataract Surgery – CHAIR.pdf\u003c\/li\u003e\n\u003cli\u003eCCV-Program-March-15-2024.pdf\u003c\/li\u003e\n\u003cli\u003eCorneal Neurotization.pdf\u003c\/li\u003e\n\u003cli\u003eCorticosteroids for Retinal Diseases- When Are They Considered; How Are They Delivered.pdf\u003c\/li\u003e\n\u003cli\u003eCurrent Management of Keratoconus- Crosslinking, Lenses, Surgery.pdf\u003c\/li\u003e\n\u003cli\u003eDMEK Complications.pdf\u003c\/li\u003e\n\u003cli\u003eEndothelial Graft Inserters.pdf\u003c\/li\u003e\n\u003cli\u003eFaricimab and High-Dose Aflibercept- Newest Anti-VEGF Agents on the Block.pdf\u003c\/li\u003e\n\u003cli\u003eIllustrative Cases.pdf\u003c\/li\u003e\n\u003cli\u003eManaging Refractive Error.pdf\u003c\/li\u003e\n\u003cli\u003eMarch 18 Cataract Surgery.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 18 Managing Refractive Error – Anterior Segment.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 19 Anterior Segment-Cornea.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 19 Other Anterior Segment Topics.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 20 Glaucoma.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 20 Retina.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 21 Retina from the Comprehensive Ophthalmologist.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 21 Uveitis.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 22 Oculoplastics and Neuro-ophthalmology.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 22 Oculoplastics and Orbit.mp4\u003c\/li\u003e\n\u003cli\u003eNon-surgical Oculoplastics Rejuvenation.pdf\u003c\/li\u003e\n\u003cli\u003eObjective and Subjective Outcomes of Extended Depth of Focus Intraocular Lenses in Patients with Ocular Pathology.pdf\u003c\/li\u003e\n\u003cli\u003eOral Corticosteroids and Immunosuppression-How to Do It.pdf\u003c\/li\u003e\n\u003cli\u003eOther Anterior Segment Topics -CHAIR.pdf\u003c\/li\u003e\n\u003cli\u003ePatient Predictors of Advanced Technology Intraocular Lens Utilization.pdf\u003c\/li\u003e\n\u003cli\u003ePort Delivery Systems for Retinal Diseases- Advantages and Safety.pdf\u003c\/li\u003e\n\u003cli\u003eRational Use of Topical Corticosteroids.pdf\u003c\/li\u003e\n\u003cli\u003eReducing Waste in Cataract Surgery- Quantifying the Problem and Implementing Solutions.pdf\u003c\/li\u003e\n\u003cli\u003eRegional Variability in Endothelial Cell Loss after Intraocular Surgery.pdf\u003c\/li\u003e\n\u003cli\u003eSevere Intraocular Inflammation with Newer Intravitreal Agents for Neovascular AMD or Geographic Atrophy.pdf\u003c\/li\u003e\n\u003cli\u003eStarting DMEK.pdf\u003c\/li\u003e\n\u003cli\u003eUpdate On Office Treatment of the Cornea Surface- Basement Membrane Opacities, Nodules, and Band Keratopathy.pdf\u003c\/li\u003e\n\u003cli\u003eUveitic Glaucoma.pdf\u003c\/li\u003e\n\u003cli\u003eWhat’s New in Managing Double Vision in Thyroid Eye Disease..pdf\u003c\/li\u003e\n\u003cli\u003eWhen to Perform DSAEK vs. DMEK.pdf\u003c\/li\u003e\n\u003cli\u003eWilmer Eye Institute Turns 100- Looking Back on the Last Century of Ophthalmology.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e*Detail:\u003cbr\u003e\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"3u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eMonday, March 18, 2024\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAccreditation Information and Agenda\u003c\/strong\u003e\u003cbr\u003e7:00AM – 7:10AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCataract Surgery – CHAIR\u003c\/strong\u003e\u003cbr\u003e7:00AM – 10:00AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCataract Surgery – CHAIR\u003c\/strong\u003e\u003cbr\u003e7:00AM – 10:00AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eInteresting and Complex Cases\u003c\/strong\u003e\u003cbr\u003e7:00AM – 7:20AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eIOL Support in Absence of Capsular Support\u003c\/strong\u003e\u003cbr\u003e7:20AM – 7:40AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCataract Surgery in Eyes Post-Vitrectomy or Other Ocular Surgeries\u003c\/strong\u003e\u003cbr\u003e7:40AM – 8:00AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eIris-Sutured IOL Repairs\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:20AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCorneal Neurotization\u003c\/strong\u003e\u003cbr\u003e8:40AM – 9:00AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAI Driven Performance Assessment Tools for Cataract Surgery\u003c\/strong\u003e\u003cbr\u003e9:00AM – 9:40AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCase Discussions\u003c\/strong\u003e\u003cbr\u003e9:40AM – 10:00AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManaging Post- Cataract Surgery Inflammation\u003c\/strong\u003e\u003cbr\u003e5:00PM – 5:20PM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManaging Refractive Error\u003c\/strong\u003e\u003cbr\u003e5:00PM – 6:00PM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManaging Refractive Error – MODERATOR\u003c\/strong\u003e\u003cbr\u003e5:00PM – 6:00PM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eIOL Exchange vs LASIK\/PRK for Refractive Surprise after Cataract Surgery\u003c\/strong\u003e\u003cbr\u003e5:20PM – 5:40PM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussion\u003c\/strong\u003e\u003cbr\u003e5:40PM – 6:00PM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussion\u003c\/strong\u003e\u003cbr\u003e5:40PM – 6:00PM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAnterior Segment Challenges and Academic Ophthalmology – MODERATOR\u003c\/strong\u003e\u003cbr\u003e6:00PM – 7:00PM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAnterior Segment Challenges and Academic Ophthalmology – MODERATOR\u003c\/strong\u003e\u003cbr\u003e6:00PM – 7:00PM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCurrent Management of Keratoconus: Crosslinking, Lenses, Surgery\u003c\/strong\u003e\u003cbr\u003e6:00PM – 6:15PM\u003cbr\u003eMichael Raizman, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWilmer Eye Institute Turns 100: Looking Back on the Last Century of Ophthalmology\u003c\/strong\u003e\u003cbr\u003e6:15PM – 6:30PM\u003cbr\u003ePeter McDonnell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdate On Office Treatment of the Cornea Surface: Basement Membrane Opacities, Nodules, and Band Keratopathy\u003c\/strong\u003e\u003cbr\u003e6:30PM – 6:45PM\u003cbr\u003eMichael Raizman, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussion\u003c\/strong\u003e\u003cbr\u003e6:45PM – 7:00PM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"3u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eTuesday, March 19, 2024\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAnterior Segment (Cornea) -CHAIR\u003c\/strong\u003e\u003cbr\u003e7:00AM – 10:00AM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAnterior Segment (Cornea) -CHAIR\u003c\/strong\u003e\u003cbr\u003e7:00AM – 10:00AM\u003cbr\u003eMark A Terry, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRegional Variability in Endothelial Cell Loss after Intraocular Surgery\u003c\/strong\u003e\u003cbr\u003e7:00AM – 7:20AM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eStarting DMEK\u003c\/strong\u003e\u003cbr\u003e7:20AM – 7:40AM\u003cbr\u003eMark A Terry, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLooking Forward: Challenges and Opportunities for Ophthalmology in the Next Decade\u003c\/strong\u003e\u003cbr\u003e7:40AM – 8:00AM\u003cbr\u003ePeter McDonnell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePatient Predictors of Advanced Technology Intraocular Lens Utilization\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:20AM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDMEK Complications\u003c\/strong\u003e\u003cbr\u003e8:40AM – 9:00AM\u003cbr\u003eMark A Terry, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOcular Surface Complications from Systemic Medications\u003c\/strong\u003e\u003cbr\u003e9:00AM – 9:20AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWhen to Perform DSAEK vs. DMEK\u003c\/strong\u003e\u003cbr\u003e9:20AM – 9:40AM\u003cbr\u003eMark A Terry, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussions\u003c\/strong\u003e\u003cbr\u003e9:40AM – 10:00AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eEndothelial Graft Inserters\u003c\/strong\u003e\u003cbr\u003e5:00PM – 5:20PM\u003cbr\u003eMark A Terry, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOther Anterior Segment Topics -CHAIR\u003c\/strong\u003e\u003cbr\u003e5:00PM – 7:00PM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOther Anterior Segment Topics -CHAIR\u003c\/strong\u003e\u003cbr\u003e5:00PM – 7:00PM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eKeratoprosthesis: Update\u003c\/strong\u003e\u003cbr\u003e5:20PM – 5:40PM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eReducing Waste in Cataract Surgery: Quantifying the Problem and Implementing Solutions\u003c\/strong\u003e\u003cbr\u003e5:40PM – 6:00PM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRole of Surgical Labs in Ophthalmic Education\u003c\/strong\u003e\u003cbr\u003e6:00PM – 6:20PM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eObjective and Subjective Outcomes of Extended Depth of Focus Intraocular Lenses in Patients with Ocular Pathology\u003c\/strong\u003e\u003cbr\u003e6:20PM – 6:40PM\u003cbr\u003eChristina R Prescott, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussions\u003c\/strong\u003e\u003cbr\u003e6:40PM – 7:00PM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"3u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eWednesday, March 20, 2024\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma – CHAIR\u003c\/strong\u003e\u003cbr\u003e7:00AM – 10:00AM\u003cbr\u003eThomas V Johnson III, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma – CHAIR\u003c\/strong\u003e\u003cbr\u003e7:00AM – 10:00AM\u003cbr\u003ePradeep Ramulu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMonitoring Glaucoma from Home\u003c\/strong\u003e\u003cbr\u003e7:00AM – 7:15AM\u003cbr\u003eThomas V Johnson III, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTrabecular MIGS\u003c\/strong\u003e\u003cbr\u003e7:15AM – 7:30AM\u003cbr\u003eJella A An, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMicroPulse Transscleral Laser Therapy\u003c\/strong\u003e\u003cbr\u003e7:30AM – 7:45AM\u003cbr\u003eJella A An, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdate on Angle Closure\u003c\/strong\u003e\u003cbr\u003e7:45AM – 8:00AM\u003cbr\u003ePradeep Ramulu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:10AM\u003cbr\u003ePradeep Ramulu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:10AM\u003cbr\u003eJella A An, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:10AM\u003cbr\u003eThomas V Johnson III, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCataract Surgery in the Glaucoma Patient- When is Phaco Enough?\u003c\/strong\u003e\u003cbr\u003e8:25AM – 8:45AM\u003cbr\u003ePradeep Ramulu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdate on Neuroprotection for Glaucoma: The Time Has Come\u003c\/strong\u003e\u003cbr\u003e8:45AM – 9:05AM\u003cbr\u003eThomas V Johnson III, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetinal Ganglion Cell Regeneration: Science Fiction or Scientific Possibility?\u003c\/strong\u003e\u003cbr\u003e9:05AM – 9:20AM\u003cbr\u003eThomas V Johnson III, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eVisual Fields – New tests, strategies, and tips for interpretation\u003c\/strong\u003e\u003cbr\u003e9:20AM – 9:40AM\u003cbr\u003ePradeep Ramulu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers\u003c\/strong\u003e\u003cbr\u003e9:40AM – 9:45AM\u003cbr\u003eThomas V Johnson III, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers\u003c\/strong\u003e\u003cbr\u003e9:40AM – 9:45AM\u003cbr\u003ePradeep Ramulu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePotential Impact of AI Chatbots: For Editors, Authors, and Readers of Peer-Reviewed Ophthalmic Literature\u003c\/strong\u003e\u003cbr\u003e9:45AM – 10:00AM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCommon Misperceptions Regarding Management of Diabetic Macular Edema, including Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists\u003c\/strong\u003e\u003cbr\u003e4:20PM – 4:40PM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetina: Chair\u003c\/strong\u003e\u003cbr\u003e4:20PM – 7:00PM\u003cbr\u003eJun Kong, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetina: Chair\u003c\/strong\u003e\u003cbr\u003e4:20PM – 7:00PM\u003cbr\u003eChristina Y. Weng, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHome OCT-Guided Treatment versus Treat and Extend for the Management of Neovascular AMD\u003c\/strong\u003e\u003cbr\u003e4:40PM – 5:00PM\u003cbr\u003eChristina Y. Weng, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCurrent Management of Proliferative Diabetic Retinopathy\u003c\/strong\u003e\u003cbr\u003e5:00PM – 5:20PM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePort Delivery Systems for Retinal Diseases: Advantages and Safety\u003c\/strong\u003e\u003cbr\u003e5:20PM – 5:40PM\u003cbr\u003eChristina Y. Weng, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDiabetic Macular Edema: Prophylaxis vs Treat when VA Loss\u003c\/strong\u003e\u003cbr\u003e5:40PM – 6:00PM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eArtificial Intelligence and Retinal Imaging\u003c\/strong\u003e\u003cbr\u003e6:00PM – 6:20PM\u003cbr\u003eJun Kong, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUltrawide Field Imaging to Manage Diabetic Retinopathy Artificial Intelligence and Retinal Imaging\u003c\/strong\u003e\u003cbr\u003e6:20PM – 6:40PM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussion\u003c\/strong\u003e\u003cbr\u003e6:40PM – 7:00PM\u003cbr\u003eChristina Y. Weng, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"3u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eThursday, March 21, 2024\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCorticosteroids for Retinal Diseases: When Are They Considered; How Are They Delivered\u003c\/strong\u003e\u003cbr\u003e7:00AM – 7:20AM\u003cbr\u003eChristina Y. Weng, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetina for The Comprehensive Ophthalmologist: Chair\u003c\/strong\u003e\u003cbr\u003e7:00AM – 11:30AM\u003cbr\u003eSusan Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetina for The Comprehensive Ophthalmologist: Chair\u003c\/strong\u003e\u003cbr\u003e7:00AM – 11:30AM\u003cbr\u003eChristina Y. Weng, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBiosimilars: They’ve Arrived in Ophthalmology\u003c\/strong\u003e\u003cbr\u003e7:20AM – 7:40AM\u003cbr\u003eSusan Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManagement of Symptomatic Epiretinal Membranes and DRCR Retina Network’s Protocol AM\u003c\/strong\u003e\u003cbr\u003e7:40AM – 8:00AM\u003cbr\u003eChristina Y. Weng, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eFaricimab and High-Dose Aflibercept: Newest Anti-VEGF Agents on the Block\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:20AM\u003cbr\u003eSusan Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eFaricimab and High-Dose Aflibercept: Newest Anti-VEGF Agents on the Block\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:20AM\u003cbr\u003eChristina Y. Weng, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManaging the Patient with Geographic Atrophy\u003c\/strong\u003e\u003cbr\u003e8:40AM – 9:00AM\u003cbr\u003eSusan Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSevere Intraocular Inflammation with Newer Intravitreal Agents for Neovascular AMD or Geographic Atrophy\u003c\/strong\u003e\u003cbr\u003e9:00AM – 9:20AM\u003cbr\u003eJun Kong, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eFalls in Ophthalmology: A Potentially Overlooked Common Problem\u003c\/strong\u003e\u003cbr\u003e9:20AM – 9:40AM\u003cbr\u003eSusan Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussion\u003c\/strong\u003e\u003cbr\u003e9:40AM – 10:00AM\u003cbr\u003eSusan Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussion\u003c\/strong\u003e\u003cbr\u003e9:40AM – 10:00AM\u003cbr\u003eChristina Y. Weng, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eImaging Workshop: A Picture is Worth A Thousand Exams\u003c\/strong\u003e\u003cbr\u003e10:15AM – 11:30AM\u003cbr\u003eSusan Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eImaging Workshop: A Picture is Worth A Thousand Exams\u003c\/strong\u003e\u003cbr\u003e10:15AM – 11:30AM\u003cbr\u003eJun Kong, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRational Use of Topical Corticosteroids\u003c\/strong\u003e\u003cbr\u003e5:00PM – 5:20PM\u003cbr\u003eMeghan Berkenstock, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUveitis -CHAIR\u003c\/strong\u003e\u003cbr\u003e5:00PM – 7:00PM\u003cbr\u003eDouglas A Jabs, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUveitis -CHAIR\u003c\/strong\u003e\u003cbr\u003e5:00PM – 7:00PM\u003cbr\u003eMeghan Berkenstock, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOral Corticosteroids and Immunosuppression:How to Do It\u003c\/strong\u003e\u003cbr\u003e5:20PM – 5:40PM\u003cbr\u003eDouglas A Jabs, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAntibody Drug Conjugate: What are They and What Does An Ophthalmologist Need to Know About Them\u003c\/strong\u003e\u003cbr\u003e5:40PM – 6:00PM\u003cbr\u003eMeghan Berkenstock, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUveitic Glaucoma\u003c\/strong\u003e\u003cbr\u003e6:00PM – 6:20PM\u003cbr\u003eDouglas A Jabs, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eIllustrative Cases\u003c\/strong\u003e\u003cbr\u003e6:20PM – 7:00PM\u003cbr\u003eMeghan Berkenstock, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eIllustrative Cases\u003c\/strong\u003e\u003cbr\u003e6:20PM – 7:00PM\u003cbr\u003eDouglas A Jabs, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"3u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eFriday, March 22, 2024\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLumps and Bumps: Management 101 for the Comprehensive Ophthalmologist\u003c\/strong\u003e\u003cbr\u003e7:00AM – 7:20AM\u003cbr\u003eSara T Wester, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOculoplastics and Orbit: Chair\u003c\/strong\u003e\u003cbr\u003e7:00AM – 10:00AM\u003cbr\u003eSophie Liao, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOculoplastics and Orbit: Chair\u003c\/strong\u003e\u003cbr\u003e7:00AM – 10:00AM\u003cbr\u003eNicholas Mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdate on the Management of Eyelid Cancers\u003c\/strong\u003e\u003cbr\u003e7:20AM – 7:40AM\u003cbr\u003eAshley Campbell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNon-surgical Oculoplastics Rejuvenation\u003c\/strong\u003e\u003cbr\u003e7:40AM – 8:00AM\u003cbr\u003eSophie Liao, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThyroid Eye Disease Update: Medical and Surgical Innovations\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:20AM\u003cbr\u003eNicholas Mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTreating the Tearing Patient\u003c\/strong\u003e\u003cbr\u003e8:40AM – 9:00AM\u003cbr\u003eSara T Wester, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBlepharoplasty Basics\u003c\/strong\u003e\u003cbr\u003e9:00AM – 9:20AM\u003cbr\u003eSophie Liao, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eComplicated Cosmetic Cases\u003c\/strong\u003e\u003cbr\u003e9:20AM – 10:00AM\u003cbr\u003eSara T Wester, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eComplicated Cosmetic Cases\u003c\/strong\u003e\u003cbr\u003e9:20AM – 10:00AM\u003cbr\u003eSophie Liao, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eComplicated Cosmetic Cases\u003c\/strong\u003e\u003cbr\u003e9:20AM – 10:00AM\u003cbr\u003eNicholas Mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eComplicated Cosmetic Cases\u003c\/strong\u003e\u003cbr\u003e9:20AM – 10:00AM\u003cbr\u003eAshley Campbell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eImaging in Oculoplastics: Fractures, Tumors, Surgical Applications\u003c\/strong\u003e\u003cbr\u003e5:00PM – 5:20PM\u003cbr\u003eNicholas Mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOculoplastics and Neuro-ophthalmology – CHAIR\u003c\/strong\u003e\u003cbr\u003e5:00PM – 7:00PM\u003cbr\u003eAndrew Carey, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOculoplastics and Neuro-ophthalmology – CHAIR\u003c\/strong\u003e\u003cbr\u003e5:00PM – 7:00PM\u003cbr\u003eNicholas Mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAcute Periorbital Infections: What Do All Ophthalmologists Need to Know\u003c\/strong\u003e\u003cbr\u003e5:20PM – 5:40PM\u003cbr\u003eAshley Campbell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNeurosurgical Approaches to the Orbit\u003c\/strong\u003e\u003cbr\u003e5:40PM – 6:00PM\u003cbr\u003eNicholas Mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWhat’s New in Managing Double Vision in Thyroid Eye Disease?\u003c\/strong\u003e\u003cbr\u003e6:00PM – 6:20PM\u003cbr\u003eAndrew Carey, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAdvanced OCT Interpretation in Neuro-ophthalmology: Beyond Average RNFL Thickness\u003c\/strong\u003e\u003cbr\u003e6:20PM – 6:40PM\u003cbr\u003eAndrew Carey, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers\u003c\/strong\u003e\u003cbr\u003e6:40PM – 6:50PM\u003cbr\u003eAndrew Carey, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers\u003c\/strong\u003e\u003cbr\u003e6:40PM – 6:50PM\u003cbr\u003eNicholas Mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eClosing Remarks and Adjourn\u003c\/strong\u003e\u003cbr\u003e6:50PM – 7:00PM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954391912546,"sku":"MED-AMB02530","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Johns-Hopkins-Wilmer-Eye-Institutes-40th-Annual-Current-Concepts-in-Ophthalmology-2024.png?v=1779375226","url":"https:\/\/meducourse.com\/products\/johns-hopkins-wilmer-eye-institutes-40th-annual-current-concepts-in-ophthalmology-2024","provider":"Meducourse","version":"1.0","type":"link"}